Glucagon-like peptide-2 enhances intestinal epithelial barrier function of both transcellular and paracellular pathways in the mouse

Gut

Volumn 47, Issue 1, 2000, Pages 112-119

  Benjamin, M A ^a   McKay, D M ^a   Yang, P C ^a   Cameron, H ^a   Perdue, M H ^a  

^a MCMASTER UNIVERSITY   (Canada)

Author keywords

Growth factors; Intestinal permeability; Macromolecular transport

Indexed keywords

EDETATE CHROMIUM; GLUCAGON LIKE PEPTIDE; GROWTH FACTOR; HORSERADISH PEROXIDASE; ISOPROTEIN; SODIUM; SODIUM CHLORIDE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ELECTRON MICROSCOPE; FEMALE; GASTROINTESTINAL TRACT FUNCTION; INTESTINE CELL; INTESTINE EPITHELIUM; INTESTINE MUCOSA PERMEABILITY; MACROMOLECULE; MORPHOLOGY; MOUSE; NONHUMAN; PHAGOCYTOSIS; PRIORITY JOURNAL; PROTEIN DETERMINATION; SODIUM CONDUCTANCE; TRANSCYTOSIS;

ANIMALS; CULTURE TECHNIQUES; EDETIC ACID; ENTEROCYTES; EPITHELIUM; FEMALE; GLUCAGON-LIKE PEPTIDE 2; GLUCAGON-LIKE PEPTIDES; HORSERADISH PEROXIDASE; INTESTINAL ABSORPTION; INTESTINAL MUCOSA; JEJUNUM; MICE; MICE, INBRED STRAINS; MICROSCOPY, ELECTRON; PEPTIDES; PERMEABILITY; SIGNAL TRANSDUCTION; SODIUM;

EID: 0033944863     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.47.1.112     Document Type: Article

References (38)

1. Bjarnason I, Macpherson A, Hollander D. Intestinal permeability: an overview. Gastroenterology 1995;10S:1566-81.
2. Meddings JB. Intestinal permeability in Crohn's disease. Aliment Pharmacol Ther 1997;11(suppl 3):47-53.
3. Sartor RB. Current concepts of the etiology and pathogenesis of ulcerative colitis and Crohn's disease. Gastroencerol Clin North Am 1995;24:475-507.
4. Ma TY. Intestinal epithelial barrier dysfunction in Crohn's disease. Proc Soc Exp Biol Med 1997;214:318-27.
5. Hadfield RJ, Sinclair DG, Houldsworth PE, et al. Effects of enteral and parenteral nutrition on gut mucosal permeability in the critically ill. AmJRespir Crit Care Med 1995;152: 1545-8.
6. Wallace JL. NSAID gastroenteropathy. Past, present and future. Can J Gastrocnterol 1996;10:451-9.
7. Saunders PR, Kosecka U, McKay DM, et al. Acute Stressors stimulate ion secretion and increase epithelial permeability in rat intestine. Am J Physio! 1994;267:G794-9.
8. Go LL, Healey PJ, Watkins SC, Simmons RL, Rowe All. The effect of endotoxin on intestinal mucosal permeability to bacteria in vitro. Arch Surg 1995;130:53-8.
9. Philpott DJ, McKay DM, Sherman P, ei al. Infection of T84 cells with enteropathogenic Escherichia coli alters barrier and transport functions. Am J Physiol 1996;270:G634-45.
10. 51Cr-EDTA in infectious diarrhea. Dig Dis Sci 1993;38:1651-7.
11. Madara JL, Stafford J. Interferon-γ directly affects barrier function of cultured intestinal epithelial monolayers. J Clin Invest 1989;83:724-7.
12. McKay DM, Croitoru K, Perdue MH. T cell-monocyte interactions regulate epithelial physiology in a co-culture model of inflammation. Am J Physiol 1996;270:C418-28.
13. Rodriguez P, Heyman M, Candalh C, et al. Tumour necrosis factor-α induces morphological and functional alterations of intestinal HT29 cl.19A cell monolayers. Cytokine 1995;7:441-8.
14. Colgan SP, Resnick MB, Parkos ÇA, et al. IL-4 directly modulates function of a model human intestinal epithelium. J Immunol 1994;153:2122-9.
15. Berin MC, Yang P-C, Ciok L, et al. Role for IL-4 in macromolecular transport across human intestinal epithelium. Am J Physiol 1999;276:C 1046-52.
16. Planchon SM, Martins CAP, Guerrant RL, el al. Regulation of intestinal epithelial barrier function by TGF-l. Evidence for its role in abrogating the effect of a T cell cytokine. .7/mmHnon994;153:5730-9.
17. Dignass AU, Podolsky DK. Cytokine modulation of intestinal epithelial cell restitution: Central role of transforming growth factor-. Gasirocnterology 1993;105:1323-32.
18. Peterson CA, Key DM, Hinton PS, el al. Beneficial effects of insulin-like growth factor I on epithelial structure and function in parenterally fed rat jejunum. Gasiroentcrology 1996;lll:1501-8.
19. Gasslander T, Permert J, Feng W, el al. Trophic effects by epidermal growth factor on duodenal mucosa and exocrine pancreas in rats. EtirSiirgRes 1997;29:142-9.
20. Hirano M, Iwakiri R, Fujimoto K, et al. Epidermal growth factor enhances repair of rat intestinal mucosa damaged by oral administration of methotrexate. J Gasiroemcrol 1995; 30:169-76.
21. Gleeson MH, Bloom SR, Polak JM, et al. Endocrine tumour in kidney affecting small bowel structure, motility, and absorptive function. Gut 1971;12:773-82.
22. Drucker DJ, Ehrlich P, Asa SL, et al. Induction of intestinal epithelial proliferation by glucagon-like peptide-2. Proc Nat AcadSciUSAl996;93:7911-16.
23. Brubaker PL, Izzo A, Hill M, et al. Intestinal function in mice with small bowel growth induced by glucagon-Iike peptide-2. Am J Phsiol 1997;272:E1050-8.
24. Lowry OH, Rosebrough NJ, Farr AL, et al. Protein measurement with the folin phenol reagent. J Biol Chem 1951;193:265-75.
25. Berin CB, Kiliaan AJ, Yang PC, et al. Rapid transepithelial antigen transport: impact of sensitization and the hypersensitivity reaction. Gastroenterology 1997;113:856-64.
26. Bijlsma PB, Kiliaan AK, Schölten G, et al. Carbachol, but not forsfcolin, increases mucosal-to-serosal transport of intact protein in rat ileum in vitro. Am J Physiol 1996;271: G147-55.
27. Tsai CH, Hill M, Asa SL, et al. Intestinal growth-promoting properties of glucagon-like peptide-2 in mice. Am J Physïol 1997;273:E77-84.
28. Tsai CH, Hill M, Drucker DJ. Biological determinants of intestinotrophic properties of GLP-2 in vivo. Am J Physiol 1997;272:G662-8.
29. Cheeseman CI, Tsang R. The effect of GIF and glucagon-Iike peptides on intestinal basolateral membrane hexose transport. Am J Physiol 1996;271:G477-82.
30. Cheeseman CI. Upregulation of SGLT-1 transport activity in rat jejunum induced by GLP-2 infusion in vivo. Am J Physiol 1997;273:R1965-71.
31. Drucker DJ, Shi Q, Crivici A, et al. Regulation of the biological activity of glucagon-like peptide 2 in vivo by dipeptidyl peptidase IV. Nat Biotcchnol 1997;15:673-7.
32. Bjarnason I, Peters TJ, Levi AJ. Intestinal permeabilit-: clinical correlates. Dig Dis Sci 1986;4:83-92.
33. Alnadjim Z, Koehler R, Kayali Z, et al. Crypt cell apoptosis and increased mucosal permeability induced by activated cells. Gastroenterology 1998;114:A348 .
34. Hollander D. The intestinal permeability barrier. A hypothesis as to its regulation and involvement in Crohn's disease. ScandJ Gastwemewl 1992;27:721-6.
35. Madara JL. Loosening tight junctions-lessons from the intestine. J Clin Invest 1989;83:1089-94.
36. Drucker DJ, Yusta B, Bouchey RP, et al. Human [Gly2] GLP-2 reduces the severity of colonie injury in a murine model of experimental colitis. Am J Physiol 1999;276:G79-91.
37. Scott RB, Kirk D, MacNaughton WK, et al. GLP-2 augments the adaptive response to massive resection in rat. Am J Plysiol 1998;27S:G911-21.
38. Chance WT, Foley-Nelson T, Thomas I, et al. Prevention of parenteral nutrition-induced gut hypoplasia by coinfusion of glucagon-like peptide-2. Am J Physiol 1997;273:G55963.